Some plans may include medical weight loss or GLP-1 coverage, while others may exclude weight-loss medications
The FDA has only approved six weight loss drugs, including: Bupropion-naltrexone (Contrave) Liraglutide (Saxenda) Orlistat (Xenical, Alli) Phentermine-topiramate (Qsymia) Semaglutide (Wegovy) Setmelanotide (Imcivree) Currently, the choice of weight loss drugs remains very limited and is divided into two main categories: pancreatic lipase inhibitors and appetite suppressants that act on the central nervous system
GLP-1 medications have become a popular option for managing type 2 diabetes and supporting weight loss
Within minutes of starting to eat, however, cells in your gut also rev into action and start secreting two peptide hormones--glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
With the potential for substantial weight reduction and improved glycemic control, GLP-1 therapy provides a comprehensive solution for patients struggling with obesity and type 2 diabetes
Patients with IIH have increased leptin levels in the CSF, whereas other patients with obesity (but without IIH) have decreased leptin levels in the CSF [9]
